Cargando…
Molecular basis for DNA cleavage by the hypercompact Cas12j-SF05
Autores principales: | Duan, Zhiqiang, Zhang, Xi, Zhang, Jun-Tao, Li, Shanshan, Liu, Ruiheng, Sun, Jie, Zhao, Qingzhi, Jia, Nannan, Jia, Ning, Zhu, Jian-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663539/ https://www.ncbi.nlm.nih.gov/pubmed/37990011 http://dx.doi.org/10.1038/s41421-023-00612-5 |
Ejemplares similares
-
In vivo treatment of tyrosinaemia with hypercompact Cas12f1
por: Guo, Ruochen, et al.
Publicado: (2023) -
Hypercompact CRISPR–Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants
por: Liu, Shishi, et al.
Publicado: (2022) -
Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus
por: Kim, Do Yon, et al.
Publicado: (2021) -
The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells
por: Farr, Christine J., et al.
Publicado: (2014) -
Cas9 has no exonuclease activity resulting in staggered cleavage with overhangs and predictable di- and tri-nucleotide CRISPR insertions without template donor
por: Shi, Xin, et al.
Publicado: (2019)